maccura(SZ:300463) Xin Lang Cai Jing·2025-10-25 02:55Core Insights - Mike Biotech (300463.SZ) released its Q3 2025 report on October 25, 2025, indicating a total of 29.2165 million A-shares held by four institutional investors, accounting for 4.83% of the total share capital [1] - The institutional holding ratio decreased by 0.39 percentage points compared to the previous quarter [1] Institutional Investors - The institutional investors include: - China Merchants Securities Asset Management - Sun Li - China Merchants Asset Management Zhenxiang Value 2025001 Single Asset Management Plan - CITIC Securities Asset Management (Hong Kong) Limited - Client Funds - Hong Kong Central Clearing Limited [1] - The total institutional holding ratio is now 4.83% [1] Public Funds - A total of 97 public funds were not disclosed in this period compared to the previous quarter, including: - Southern CSI 1000 ETF - Huaxia CSI 1000 ETF - GF CSI 1000 ETF - Huitianfu Precision Medical Index (LOF) A - Medical Device ETF [1] Foreign Investment - One foreign fund, Hong Kong Central Clearing Limited, reduced its holdings by 0.12% compared to the previous quarter [1] - A new foreign institution disclosed this quarter is CITIC Securities Asset Management (Hong Kong) Limited - Client Funds [1]